Semi-Annual Consolidated Statement Of Income

Delta-Fly Pharma, Inc. - Filing #7597815

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual consolidated statement of income
Statement of income
Ordinary profit (loss)
-964,064,000 JPY
-859,372,000 JPY
Selling, general and administrative expenses
Remuneration for directors (and other officers)
87,825,000 JPY
84,375,000 JPY
Taxes and dues
34,038,000 JPY
33,305,000 JPY
Profit (loss) before income taxes
-964,064,000 JPY
-859,372,000 JPY
Operating profit (loss)
-961,462,000 JPY
-852,231,000 JPY
Non-operating income
Interest income
70,000 JPY
227,000 JPY
Non-operating income
190,000 JPY
438,000 JPY
Income taxes - current
3,237,000 JPY
3,213,000 JPY
Non-operating expenses
Interest expenses
JPY
43,000 JPY
Non-operating expenses
2,793,000 JPY
7,578,000 JPY
Income taxes
3,237,000 JPY
3,213,000 JPY
Profit (loss)
-967,302,000 JPY
-967,302,000 JPY
-967,302,000 JPY
-967,302,000 JPY
-862,585,000 JPY
-862,585,000 JPY
-862,585,000 JPY
-862,585,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.